Opportunity for channel partnerships and venture capital investor participation with a technology leader in the ophthalmology industry.
Interview with John Hendrick – President & CEO of Mynosys Cellular Devices, Inc.
Meet John Hendrick – President & CEO of Mynosys Cellular Devices, Inc. as he discusses their company's technology which could revolutionize the way ophthalmologists conduct cataract surgery. The company is proceeding rapidly toward FDA approval of its medical devices. The company's technology has been used in numerous eye surgeries outside the U.S. with great success.
About John Hendrick
John Hendrick is the president and CEO of Mynosys Cellular Devices Inc. He has over 30 years of executive experience in medical device industry. Previously, he was CEO of NeoVista Inc and head of Medical Division of Sanmina-Sci. He was also involved in a successful IPO of VidaMed, and has held executive positions in Baxter and American Hospital Supply, Allergan Medical Optics, and other board positions.